Vitamin E Vitamin E


Statin Use Linked to Increased Parkinson's Risk

New findings from a large national database show that the use of cholesterol-lowering statin drugs are associated with an increased risk for Parkinson’s disease — contrary to previous research suggesting just the opposite, Medscape reports.

Researchers speculated that one possibility for this was that statins block the synthesis of coenzyme Q10 (CoQ10) — something I’ve been saying for years. One the most widely prescribed drugs on the market, statins deplete your body of CoQ10, inhibit synthesis of vitamin K2, and reduce the production of ketone bodies. And besides Parkinson’s, they increase your risk of serious diseases such as cancer, diabetes, neurodegenerative diseases, musculoskeletal disorders and cataracts.

I can’t stress enough how important CoQ10 is for your body. It’s used for energy production by every cell in your body, and is therefore vital for good health, high energy levels, longevity, and general quality of life. CoQ10’s reduced form, ubiquinol, is a critical component of cellular respiration and production of adenosine triphosphate (ATP). When you consider that your heart is the most energy-demanding organ in your body, you can surmise how potentially devastating it can be to deplete your body's main source of cellular energy.

So while one of statins' claims to fame is warding off heart disease, you're actually increasing your risk when you deplete your body of CoQ10.

If you're on a statin drug, you need to take 100-200 mg of CoQ10 or ubiquinol daily. You cannot get enough of it through your diet. You also need a vitamin K2 supplement. Professor Cees Vermeer, one of the world’s top vitamin K2 researchers, recommends between 45 mcg and 185 mcg daily for adults. javascript:void(0);
Click Here and be the first to comment on this article
Post your comment